Fundraising Fox

Acepodia

Founded 2016 · 61 employees on LinkedIn · 2 known investors

Find your way into Acepodia

78 people in our graph share verified history with the Acepodia team — schools, employers, funds. One of them is your warm intro.

Noubar Afeyanunlockedknows Patrick Y. Yang · together at Sana Biotechnology (overlapped)
knows the team · via AltruBio Inc.
knows the team · via Antheia, Inc.
×9knows the team · via University of Cincinnati

Acepodia develops cell therapies for cancer treatment, leveraging proprietary immune cell engineering and tumor-targeting technology to create off-the-shelf therapeutic options for broad patient populations.

BiotechHealthtechMedical Devices

Founders & leadership

Acepodia was founded in 2016 by Patrick Y. Yang and Sonny Hsiao.

PYPatrick Y. Yang
Patrick Y. YanginCo-founder, former EVP of Juno Therapeutics, Roche and GenentechPatrick Y. Yang is co-founder of Acepodia and formerly served as Executive Vice President at Juno Therapeutics, as well as holding roles at Roche and Genentech. He has expertise in biotech process research, development, manufacturing, and supply chain across operations in the U.S., Asia/Pacific, and Europe.
SH
Sonny HsiaoCo-founder, UC Berkeley cell biologist

Investors · 2

Maxpro VenturesTaipei · $10M – $13M

Also in the syndicate · 1

Digital Mobile Venturelead

Funding

SEC filings, press & company announcements

$209M disclosed across 2 rounds · 2021–2023

  • $100MSeries DJun 2023 · 2 sources

    Digital Mobile Venture (lead)

    Source ↗
  • $109MSeries CDec 2021 · 2 sources
    Source ↗

Source: company announcements and press reports — follow each round's link for the claim.

In the news

Acepodia Wins FDA Clearance For IND Of ACE723 In Liver Cancerrttnews.com · Sep 2026Acepodia raises $100M financing to boost cell therapieslabiotech.eu · Jun 2023Acepodia raises funds to advance pipeline of cell therapiespharmaceutical-technology.com · Jun 2023Acepodia Raises $109 Million Series C Financing to Advance Development of First-in-Class Antibody Cell Effector Therapies - BioSpacebiospace.com · Dec 2021Acepodia Raises $109 Million Series C Financing to Advance Development of First-in-Class Antibody Cell Effector Therapiesglobenewswire.com · Dec 2021Acepodia Raises $47 Million Funding to Nurture its Next-Gen, oNK Cell Therapy Assets - GeneOnline Newsgeneonline.com · Mar 2021

Frequently asked questions

What does Acepodia do?
Acepodia develops cell therapies for cancer treatment, leveraging proprietary immune cell engineering and tumor-targeting technology to create off-the-shelf therapeutic options for broad patient populations.
Who founded Acepodia?
Acepodia was founded by Patrick Y. Yang, Sonny Hsiao in 2016.
Who are Acepodia's investors?
Acepodia's investors include Maxpro Ventures.
How much funding has Acepodia raised?
Acepodia has disclosed $209M raised across 2 rounds.